PR Newswire10.14.21
NuVasive Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today launched the Cohere TLIF-O implant and announced the upcoming launch of the Cohere TLIF-A implant later this quarter. With these additions to its Advanced Materials Science (AMS) portfolio, NuVasive is the only company to offer both porous PEEK and porous titanium implants for posterior spine surgery.1
"NuVasive is focused on providing a comprehensive spine offering across all procedural segments to address some of the most challenging aspects of spine surgery. Porous PEEK is a clear differentiator for us in the market, and the launch of Cohere TLIF-O and future addition of Cohere TLIF-A furthers our commitment to this one-of-a-kind technology," said Massimo Calafiore, chief commercial officer of NuVasive. "The company has a uniquely differentiated TLIF portfolio to support the most widely used posterior spine procedure and we will continue to invest in outcome-driven innovation that drives the greatest impact for our surgeons, providers, and patients."
Cohere TLIF-O is a porous PEEK implant for the transforaminal lumbar interbody fusion (TLIF) procedure with a variety of implant sizes to accommodate various patient anatomies and procedurally designed instrumentation. Its design adheres to NuVasive's AMS principles of surface, structure, and imaging and includes the following features:
"Porous PEEK combines the stiffness and radiolucency of PEEK with the enhanced osseo-integration of the porous technology—benefits not possible with prior devices," said Frank Phillips, M.D., professor of orthopedic surgery and director of the Division of Spine Surgery at Rush University Medical Center in Chicago. "The enhanced clinical outcomes possible with Cohere TLIF-O and the comprehensive surface technology options for posterior spine surgery now available are helping advance the standard of patient care."
Later in the fourth quarter, the company plans to launch the Cohere TLIF-A implant. While the device has similar clinical properties to Cohere TLIF-O, the Cohere TLIF-A implant is designed for anterior column support to maximize sagittal alignment correction.
NuVasive's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. Its procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than $1 billion in net sales, NuVasive has approximately 2,700 employees and operates in more than 50 countries serving surgeons, hospitals, and patients.
References
1 Data on file. Based on review of publicly available materials at the time of this release.
2 Torstrick FB, Safranski DL, Burkus JK, et al. Getting PEEK to stick to bone: the development of porous PEEK for interbody fusion devices. Tech Orthop 2017;32:158-166. Data may not be representative of clinical results.
3 Torstrick FB, Lin ASP, Gall K, et al. Porous PEEK improves the bone-implant interface compared to plasma-sprayed titanium coating in PEEK: in vitro and in vivo analysis. Transactions of the 2017 Annual Meeting of the ORS, San Diego, CA; Poster 0835. Data may not be representative of clinical results.
4 Torstrick FB, Evans NT, Stevens HY, et al. Do surface porosity and pore size influence mechanical properties and cellular response to PEEK? Clin Orthop Relat Res2016;474(11):2373-83. Data may not be representative of clinical results.
"NuVasive is focused on providing a comprehensive spine offering across all procedural segments to address some of the most challenging aspects of spine surgery. Porous PEEK is a clear differentiator for us in the market, and the launch of Cohere TLIF-O and future addition of Cohere TLIF-A furthers our commitment to this one-of-a-kind technology," said Massimo Calafiore, chief commercial officer of NuVasive. "The company has a uniquely differentiated TLIF portfolio to support the most widely used posterior spine procedure and we will continue to invest in outcome-driven innovation that drives the greatest impact for our surgeons, providers, and patients."
Cohere TLIF-O is a porous PEEK implant for the transforaminal lumbar interbody fusion (TLIF) procedure with a variety of implant sizes to accommodate various patient anatomies and procedurally designed instrumentation. Its design adheres to NuVasive's AMS principles of surface, structure, and imaging and includes the following features:
- Surface: The implant's proprietary porous surface technology generates stronger integration through bony in-growth and on-growth2 in comparison to smooth PEEK,3,4 which aids fusion and overall clinical outcomes;
- Structure: Cohere TLIF-O is designed with lordosis in the oblique plane which helps maintain coronal alignment while restoring sagittal balance; and
- Imaging: The radiolucent polymer composition of porous PEEK enables clear radiographic visualization of the fusion site with a variety of different imaging modalities.
"Porous PEEK combines the stiffness and radiolucency of PEEK with the enhanced osseo-integration of the porous technology—benefits not possible with prior devices," said Frank Phillips, M.D., professor of orthopedic surgery and director of the Division of Spine Surgery at Rush University Medical Center in Chicago. "The enhanced clinical outcomes possible with Cohere TLIF-O and the comprehensive surface technology options for posterior spine surgery now available are helping advance the standard of patient care."
Later in the fourth quarter, the company plans to launch the Cohere TLIF-A implant. While the device has similar clinical properties to Cohere TLIF-O, the Cohere TLIF-A implant is designed for anterior column support to maximize sagittal alignment correction.
NuVasive's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. Its procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than $1 billion in net sales, NuVasive has approximately 2,700 employees and operates in more than 50 countries serving surgeons, hospitals, and patients.
References
1 Data on file. Based on review of publicly available materials at the time of this release.
2 Torstrick FB, Safranski DL, Burkus JK, et al. Getting PEEK to stick to bone: the development of porous PEEK for interbody fusion devices. Tech Orthop 2017;32:158-166. Data may not be representative of clinical results.
3 Torstrick FB, Lin ASP, Gall K, et al. Porous PEEK improves the bone-implant interface compared to plasma-sprayed titanium coating in PEEK: in vitro and in vivo analysis. Transactions of the 2017 Annual Meeting of the ORS, San Diego, CA; Poster 0835. Data may not be representative of clinical results.
4 Torstrick FB, Evans NT, Stevens HY, et al. Do surface porosity and pore size influence mechanical properties and cellular response to PEEK? Clin Orthop Relat Res2016;474(11):2373-83. Data may not be representative of clinical results.